noevir holdingsnoevir holdings co.,ltd.4928東証プライム化学FY ending Sep 2025, consolidated, J-GAAP

noevir holdings revenue and profit

Out of every ¥100 of sales, about ¥17 is left as operating profit. Revenue changed +1.4% from the prior year, operating profit -3.0%.

Five-year trend

Revenue¥64.7B
FY ending Sep 2021: ¥51.3B¥51.3BFY ending Sep 2022: ¥61.1B¥61.1BFY ending Sep 2023: ¥62.6B¥62.6BFY ending Sep 2024: ¥63.8B¥63.8BFY ending Sep 2025: ¥64.7B¥64.7BFY21FY22FY23FY24FY25
Operating income¥11.1B
FY ending Sep 2021: ¥8.56B¥8.56BFY ending Sep 2022: ¥10.1B¥10.1BFY ending Sep 2023: ¥11B¥11BFY ending Sep 2024: ¥11.4B¥11.4BFY ending Sep 2025: ¥11.1B¥11.1BFY21FY22FY23FY24FY25
Operating margin17.1%
FY ending Sep 2021: 16.7%16.7%FY ending Sep 2022: 16.5%16.5%FY ending Sep 2023: 17.6%17.6%FY ending Sep 2024: 17.9%17.9%FY ending Sep 2025: 17.1%17.1%FY21FY22FY23FY24FY25

What drives ROE

Net margin × asset turnover = ROA; ROA × financial leverage = ROE

Net margin12.4%
Asset turnover0.85×
ROA10.5%
ROA10.5%
Financial leverage1.49×
ROE15.7%

Denominators: average assets and average equity. Derived from reported values; ROE is shown only for positive profit and equity.

Net margin12.4%
2021: 12.4%12.4%2022: 12.4%12.4%2023: 12.3%12.3%2024: 12.5%12.5%2025: 12.4%12.4%2122232425
Asset turnover0.85×
2021: 0.64×0.64×2022: 0.78×0.78×2023: 0.81×0.81×2024: 0.83×0.83×2025: 0.85×0.85×2122232425
ROA10.5%
2021: 7.9%7.9%2022: 9.7%9.7%2023: 10.0%10.0%2024: 10.4%10.4%2025: 10.5%10.5%2122232425
Financial leverage1.49×
2021: 1.60×1.60×2022: 1.56×1.56×2023: 1.53×1.53×2024: 1.51×1.51×2025: 1.49×1.49×2122232425
ROE15.7%
2021: 12.7%12.7%2022: 15.1%15.1%2023: 15.2%15.2%2024: 15.7%15.7%2025: 15.7%15.7%2122232425
PeriodNet marginAsset turnoverROAFinancial leverageROE
202112.4%0.64×7.9%1.60×12.7%
202212.4%0.78×9.7%1.56×15.1%
202312.3%0.81×10.0%1.53×15.2%
202412.5%0.83×10.4%1.51×15.7%
202512.4%0.85×10.5%1.49×15.7%

Financial leverage can raise ROE; a higher value alone does not describe a company's overall condition.

Asset intensity and goodwill

Annual trends in tangible-asset ratios and goodwill balance.

PPE ÷ revenue33.1%
2020: 44.4%44.4%2021: 43.0%43.0%2022: 33.8%33.8%2023: 32.3%32.3%2024: 31.2%31.2%2025: 33.1%33.1%202122232425
PPE ÷ total assets28.0%
2020: 28.8%28.8%2021: 27.4%27.4%2022: 26.9%26.9%2023: 26.1%26.1%2024: 26.0%26.0%2025: 28.0%28.0%202122232425
Goodwill ÷ parent equity0.2%
2020: 0.5%0.5%2021: 0.5%0.5%2022: 0.4%0.4%2023: 0.4%0.4%2024: 0.3%0.3%2025: 0.2%0.2%202122232425
Goodwill balance¥125M
2020: ¥271M¥271M2021: ¥240M¥240M2022: ¥209M¥209M2023: ¥178M¥178M2024: ¥158M¥158M2025: ¥125M¥125M202122232425

Ratios are derived from reported values. Goodwill is shown only when separately reported; it is not inferred from combined intangible assets. Definition

Investment and working-capital efficiency

Track R&D investment and how long operating capital remains tied up before sales turn into cash.

R&D spending¥1.13B
2020: ¥1.06B¥1.06B2021: ¥1.04B¥1.04B2022: ¥1.06B¥1.06B2023: ¥1.03B¥1.03B2024: ¥1.07B¥1.07B2025: ¥1.13B¥1.13B202122232425
R&D / revenue1.8%
2020: 2.1%2.1%2021: 2.0%2.0%2022: 1.7%1.7%2023: 1.6%1.6%2024: 1.7%1.7%2025: 1.8%1.8%202122232425
Receivable days68d
2020: 65d65d2021: 66d66d2022: 54d54d2023: 61d61d2024: 62d62d2025: 68d68d202122232425
Payable days55d
2020: 42d42d2021: 52d52d2022: 56d56d2023: 53d53d2024: 52d52d2025: 55d55d202122232425

R&D is shown only for years with machine-readable disclosure. Days are estimates using year-end receivables, inventory and payables divided by annual revenue or cost of sales; financial companies are excluded.

Income statement (JPY millions)

ItemFY ending Sep 2021FY ending Sep 2022FY ending Sep 2023FY ending Sep 2024FY ending Sep 2025
Revenue51,27261,14362,55263,82364,724
Cost of revenue18,24119,05019,98820,66621,446
Gross profit33,03142,09342,56443,15643,278
SG&A24,47331,97731,54031,73332,202
Operating income8,55710,11511,02411,42311,075
Pretax income8,96611,16111,29811,61911,879
Income tax2,5063,5063,4843,5303,690
Net income attributable to owners6,3837,5897,6737,9708,030
Operating margin16.7%16.5%17.6%17.9%17.1%

Balance sheet (reported items)

Year-end figures from filings. Unreported items are omitted. Interest-bearing debt excludes lease liabilities.

Assets

Cash 35%
Receivables 16%
Property, plant and equipment 28%
1%
4%
Other assets 16%

Funding

4%
Other liabilities 25%
Equity 71%

Each bar totals 100% of assets; other is the residual.

ItemFY ending Sep 2021FY ending Sep 2022FY ending Sep 2023FY ending Sep 2024FY ending Sep 2025
Cash and equivalents¥30.8B¥29.5B¥26.2B¥29B¥26.7B
Total assets¥80.4B¥76.8B¥77.2B¥76.5B¥76.5B
Net assets¥52.2B¥52.4B¥53.2B¥53.9B¥54.2B
Share capital¥7.32B¥7.32B¥7.32B¥7.32B¥7.32B
Trade receivables¥9.31B¥8.97B¥10.5B¥10.8B¥12.1B
Property, plant and equipment¥22B¥20.7B¥20.2B¥19.9B¥21.4B
Intangible assets excluding goodwill¥431M¥418M¥699M¥994M¥1.18B
Goodwill¥240M¥209M¥178M¥158M¥125M
Investment securities¥2.78B¥2.13B¥2.61B¥3.11B¥2.87B
Current assets¥51.1B¥50.6B¥51.2B¥50.1B¥48.9B
Current liabilities¥8.64B¥9.65B¥10.5B¥9.32B¥9.85B
Trade payables¥2.59B¥2.94B¥2.9B¥2.95B¥3.24B
Total liabilities¥28.2B¥24.4B¥24B¥22.6B¥22.3B
Non-controlling interests¥306M¥328M¥415M¥428M¥441M
Equity attributable to owners of parent¥50.4B¥50.3B¥50.6B¥51.1B¥51.4B
Retained earnings¥43B¥43B¥43.3B¥43.8B¥44.1B
Treasury stock-¥1M-¥1M-¥1M-¥2M-¥2M

Sources

Show source documents (6)
  • EDINET (FSA Japan)

    有価証券報告書-第15期(2024/10/01-2025/09/30)

    ID S100X8TQ2025-12-08Open
  • EDINET (FSA Japan)

    訂正有価証券報告書-第14期(2023/10/01-2024/09/30)

    ID S100WQSD2025-09-25Open
  • EDINET (FSA Japan)

    有価証券報告書-第13期(2022/10/01-2023/09/30)

    ID S100SEXP2023-12-08Open
  • EDINET (FSA Japan)

    訂正有価証券報告書-第12期(令和3年10月1日-令和4年9月30日)

    ID S100PS6R2022-12-12Open
  • EDINET (FSA Japan)

    有価証券報告書-第11期(令和2年10月1日-令和3年9月30日)

    ID S100MYPB2021-12-06Open
  • EDINET (FSA Japan)

    有価証券報告書-第10期(令和1年10月1日-令和2年9月30日)

    ID S100KAP22020-12-04Open

Extracted from XBRL: 52 / Derived from other figures: 1

Spotted an error? Report it (corrections keep the original record)

Analyze this page with AI

Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.